Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials.

Author: AklE A, BerwangerO, BrielM, ChongG, EyawoO, GhementI, GuyattG, MillsE J, SinghS, WuP

Paper Details 
Original Abstract of the Article :
BACKGROUND: Statins represent the largest selling class of cardiovascular drug in the world. Previous randomized trials (RCTs) have demonstrated important clinical benefits with statin therapy. AIM: We combined evidence from all RCTs comparing a statin with placebo or usual care among patients with...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1093/qjmed/hcq165

データ提供:米国国立医学図書館(NLM)

Statins: A Comprehensive Review of Their Efficacy and Safety

Cardiovascular disease is a global health concern, like a vast desert stretching across continents. Statins, a class of drugs that lower cholesterol levels, have emerged as a vital tool in the fight against this silent killer. This comprehensive meta-analysis, published in [Journal Name], reviews the efficacy and safety of statin treatment for cardiovascular disease, analyzing data from over 170,000 patients across 76 randomized controlled trials.

Statins: A Proven Benefit for Cardiovascular Health

The authors provide compelling evidence that statin therapy significantly reduces the risk of major cardiovascular events, including all-cause mortality, cardiovascular disease mortality, heart attacks, strokes, and revascularizations. It's like discovering a series of oases in the desert, offering protection from the dangers of cardiovascular disease. These findings solidify statins' position as a cornerstone of cardiovascular disease prevention and management.

Navigating the Desert of Cardiovascular Risk: A Statin Strategy

This meta-analysis provides valuable information for healthcare providers and patients seeking to manage cardiovascular risk. It's like having a comprehensive map to navigate the desert of cardiovascular disease, guiding us towards a healthier future. The evidence strongly supports the use of statins in a broad range of populations, including those with and without prior coronary heart disease.

Dr.Camel's Conclusion

This comprehensive meta-analysis provides overwhelming evidence for the efficacy and safety of statins in preventing and managing cardiovascular disease. It's like finding a treasure trove of knowledge in the desert of cardiovascular research, offering a roadmap to a healthier future. As Dr.Camel, I encourage individuals at risk for cardiovascular disease to consult with their healthcare providers to discuss the potential benefits of statin therapy. With proper management, we can navigate the desert of cardiovascular risk and create a healthier future.

Date :
  1. Date Completed 2011-05-06
  2. Date Revised 2022-03-18
Further Info :

Pubmed ID

20934984

DOI: Digital Object Identifier

10.1093/qjmed/hcq165

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.